What's new

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 37, Status: Authorised

Feb 27, 2025 - 10:28
 0
Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 37, Status: Authorised
Human medicines European public assessment report (EPAR): Xalkori, crizotinib, Date of authorisation: 23/10/2012, Revision: 37, Status: Authorised
Read More

Tags:

Previous Article

EU Green Deal: A Growth Strategy for New Economic and Business Models

Next Article

Human medicines European public assessment report (EPAR): Spinraza, nusinersen, ...

Related Posts

EMEA-002904-PIP01-20-M01

EMEA-002904-PIP01-20-M01

Feb 19, 2025  0

Human medicines European public assessment report (EPAR): Keytruda, pembrolizumab, Date of authorisation: 17/07/2015, Revision: 63, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Orphan designation: Elraglusib Treatment of soft tissue sarcoma, 16/01/2025 Positive

Orphan designation: Elraglusib Treatment of soft tissue...

Feb 20, 2025  0